On 15 July 2019, Johnson & Johnson (NYSE:JNJ) has shown upward/downward move of +0.31% and ended the last trade at $134.71. The trading volume was recorded to 9,780,901 shares as compared to average traded volume of 7,132,195 shares. Analysts mean Recommendation on a stock is noted at 2.30. Analyst Recommendation is an outlook of a stock-market analyst on a stock. Rating Scale: 1.0 represent “Strong Buy” and 2.0 signify “Buy” 3.0 while shows “Hold”. 4.0 display “Sell” and 5.0 reveal “Strong Sell” rating. EPS growth in past five years was 3.10% while EPS growth in next five years is projected to arrive at 6.48%.
Johnson & Johnson (JNJ) recently reported that its Board of Directors has reported a cash dividend for the third quarter of 2019 of $0.95 per share on the company's ordinary stock. The dividend is payable on September 10, 2019 to shareholders of record at the close of business on August 27, 2019. The ex-dividend date is August 26, 2019.
Net profit margin of the firm was recorded at 18.00% and operating profit margin was calculated at 20.80% while gross profit margin was measured as 66.90%. Beta factor, which measures the riskiness of the security, was registered at 0.69.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three sections: Consumer, Pharmaceutical, and Medical Devices.
Johnson & Johnson (JNJ) recently reported that its Board of Directors has reported a cash dividend for the third quarter of 2019 of $0.95 per share on the company's ordinary stock. The dividend is payable on September 10, 2019 to shareholders of record at the close of business on August 27, 2019. The ex-dividend date is August 26, 2019.
Net profit margin of the firm was recorded at 18.00% and operating profit margin was calculated at 20.80% while gross profit margin was measured as 66.90%. Beta factor, which measures the riskiness of the security, was registered at 0.69.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three sections: Consumer, Pharmaceutical, and Medical Devices.
)
